PenderFund Capital Management »

Orchard Therapeutics shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Orchard Therapeutics shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Orchard Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orchard Therapeutics held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orchard Therapeutics by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $514k 24k 21.80

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
PAR Technology Corporation (PAR)
Burford Cap Ord Shs (BUR)
Sangoma Technologies Corp Com New (SANG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Nuveen Insd Dividend Advantage (NVG)
Docebo (DCBO)
Kkr & Co (KKR)
Morgan Stanley Emerging Markets Domestic (EDD)

View all positions for PenderFund Capital Management

Top funds holding Orchard Therapeutics

Blue Owl Capital Holdings
Beryl Capital Management
Federated Investors
LMR Partners
Tudor Investment Corporation
Millennium Management
Goldman Sachs Group
CSS
ADAR1 Capital Management
Bck Capital Management
Jane Street
Jpmorgan Chase & Co
Hrt Financial
PenderFund Capital Management
FNY Investment Advisers

View all funds holding Orchard Therapeutics